Krystal Biotech Inc (KRYS)
Debt-to-equity ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 946,380 | 778,641 | 522,231 | 593,576 | 292,084 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $946,380K
= 0.00
Based on the provided data, Krystal Biotech Inc has consistently maintained a debt-to-equity ratio of 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not utilized any debt financing during this period and has relied solely on equity to finance its operations and growth. A debt-to-equity ratio of 0.00 signifies a conservative financial structure with no debt obligations, which can be viewed positively by investors and creditors as it implies lower financial risk and greater financial stability. However, it is important to note that while a low debt-to-equity ratio can be a sign of financial strength, it may also suggest limited access to the tax benefits associated with debt financing.
Peer comparison
Dec 31, 2024